Sight Sciences, Inc. — Director's Dealing 2021

Jul 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sight Sciences, Inc. (SGHT)
CIK: 0001531177
Period of Report: 2021-07-19

Reporting Person: Offer Andrew (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-19	Common Stock	C	3162	—	Acquired	3162	Direct
2021-07-19	Common Stock	C	2225752	—	Acquired	2355062	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-19	Series C Preferred Stock	$	C	1581	Disposed		Common Stock (3162)	Direct
2021-07-19	Series A Redeemable Convertible Preferred Stock	$	C	1086956	Disposed		Common Stock (2173912)	Indirect
2021-07-19	Series B Redeemable Convertible Preferred Stock	$	C	25920	Disposed		Common Stock (51840)	Indirect

Footnotes

F1: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering.

F2: These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II.